Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. (8th July 2013) - Kim, M.; Li, M.; Intong, L.R.A.; Tran, K.; Melbourne, W.; Marucci, D.; Bucci, J.; de Souza, P.; Mallesara, G.; Murrell, D.F.